36.7 F
New York
Thursday, April 22, 2021

Gilead Sciences [NASDAQ: GILD] To Acquire Tizona Therapeutics For $300 Million

Must read

Palantir [NYSE: PLTR] Recognized as a Crown Commercial Service supplier

Palantir Technologies Inc. has gained recognition as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework. This award...

Trevena [NASDAQ: TRVN] Soar on Selection of TRV027in Global COVID-19 Trial

Shares of Trevena, Inc. skyrocketed more than 5 percent during the pre-market trading session of Wednesday. The strong performance of the firm indicated...

InfuSystem Announces Acquisition of OB Healthcare Corporation

InfuSystem Holdings Inc. disclosed Wednesday that it has bought OB Healthcare Corporation. As per the acquisition agreement, the firm has purchased the operating...

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

Gilead Sciences, Inc. [NASDAQ: GILD] disclosed today it has acquired 49.9% equity interest in Tizona Therapeutics, Inc. for $300 million. Tizona Therapeutics, Inc. is a privately held firm engaged in the making of first-in-class immunotherapies.

Gilead Sciences also has the option to acquire the remaining shares of Tizona in an additional $1.25 billion, including an option exercise fee and future milestone payments. Gilead Sciences has the opportunity to buy the remainder of Tizona before or following the readout of Phase 1b study of Tizona’s investigational antibody, TTX-080.

Investigational antibody TTX-080 discovered by Tizona is a first-in-class drug that targets HLA-G. US Food and Drug Authority has given the all-clear for the application of TTX-080. Tizona is planning to start the phase 1 clinical trial to check TTX-080 both as monotherapy and in combination with other agents in patients with advanced cancers.

Shares of Gilead Sciences have exhibited a change of 0.67% during the trading of Tuesday. It has a day low and high range of $77.20-$77.89, respectively. GILD has a closing price of $77.56 and has opened at $77.46. In the past 52-weeks of trading, this company’s stocks have changed between the low of $60.89 and a high of $85.97.

If we turn our focus on profitability, it has a return on assets of 8.10%, its return on equity is 22.60% and return on investment is 9.50%. This company’s gross margin is 79.40%, the profit margin is 21.80% and an operating margin is 19.60%.

More articles

Latest article

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...